The global market for energy-based ablation devices in 2011 stood at $11.5 billion.
“Ablation” is considered in the context of medical technology to be a therapeutic destruction and sealing of tissue. As general as this effect on tissue can be, its clinical applications — from cancer to cardiology, urology to ophthalmology and all manner of general surgical procedures — is as broad a therapeutic range as any medical technology on the market.
The technologies represented in clinical practice are, by type of energy:
- Thermal (other than cryotherapy)
The MedMarket Diligence report #A145, “Ablation Technologies Worldwide Market, 2009-2019”, is considered the most comprehensive global report on the products, technologies, and the current and forecast global, regional and country-specific markets. In this report, the market for the spectrum of ablation technologies has been analyzed, considering current and emerging products and companies, by modality (energy type) and country to 2019.
The dominant market is the U.S., representing a full 43% of the global market (and for this reason needs to be shown on a different y-axis scale than all other country markets for ablation) :
Source: Report #A145.